Analysts’ September Coverage Rating for Spectrum Pharmaceuticals
Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) is a biotechnology company with a market cap of $857.70 million. The company specialized in the development and commercialization of oncology and hematology drugs. Despite operating through negative earnings currently, Spectrum ... [Read]
Intercept Pharmaceuticals Stock Is Falling Today, Here’s Why
As of 10:30 a.m. EDT, shares of Intercept Pharmaceuticals (NASDAQ:$ICPT) declined by 17%. Why? Many speculate the fall was caused by a letter that was sent by Intercept’s Chief Medical Officer to the medical community ... [Read]
Idera Pharmaceuticals Climbs 16.9%, Phase 3 Study Proceeds
A clinical-stage biotech company advancing novel therapies for skin-related diseases, Idera Pharmaceuticals Inc. (NASDAQ:$IDRA) saw its shares surge today. This came after the company presented trial results at the annual European Society for Medical Oncology ... [Read]
Here’s Why Immune Design is Down 6.8% Since the Last Earnings Report
Plummeting 6.8%, way outperforming the market, Immune Design Corp. (NASDAQ:$IMDZ)’s shares are suffering a serious outlook. Let’s take a look back on Immune Design’s last earnings report. Narrower-than-expected Loss in Q2 The company incurred 2Q17 ... [Read]
The Market Empties On Otonomy Inc. Stock
Following truly abysmal results from a pivotal Phase 3 trial for its steroid candidate Otividex, Otonomy Inc. (NASDAQ:$OTIC) saw its investors parachuting out of their shares. The number? A cool 81.5% decrease. While about 600,000 ... [Read]
Cara Therapeutics Stock Increases After Revealing Promising Data From a Phase 1 Drug Trial
On Wednesday, Cara Therapeutics (NASDAQ:$CARA) stock increased after the biotech company revealed promising data from a Phase 1 drug trial for chronic kidney disease patients. If you’re a biotech investor, you are probably aware of ... [Read]
Celsion Corp’s Stock Increased Almost 25% Today
On Wednesday, July 5, in a morning trading session, shares of Celsion Corp. (NASDAQ:$CLSN) increased almost 25% to $2.53. This jump occurred after the New Jersey-based firm disclosed the completion of the Ovation study, a ... [Read]
A British Biotech Company is Close to a Breakthrough Blood Test for Diagnosing Ovarian Cancer
On Monday, U.K-based biotech company Angle plc (OTCQX:$ANPCY) disclosed the trial results of a possible breakthrough blood test for diagnosing ovarian cancer. Essentially, Angle’s blood test could allow for a quicker diagnosis and referral for women ... [Read]
Should You Invest in Conatus Pharmaceuticals Inc.?
Conatus Pharmaceuticals Inc. (NASDAQ:$CNAT), a biotech-pharmaceutical company focused on developing drugs to treat liver disease, has been seeing quite a rise in its stocks recently. This can be largely due to the company’s announcement a ... [Read]
NewLink Genetics Stocks Crash after Roche Holdings Back Out of Co-Development Deal
The Upshot An unexpected decision made by Roche Holding (NASDAQOTH:$RHHBY), a healthcare company based in Basel, Switzerland, has sent the shares of NewLink Genetics Corporation (NASDAQ:$NLNK), a biotech research company focusing on cancer treatments based ... [Read]